Excelsior Medical Co., Ltd. (TPE:4104)
Taiwan · Delayed Price · Currency is TWD 77.50
+0.60 (0.78%)
At close: Mar 27, 2026
Excelsior Medical Revenue
In the year 2025, Excelsior Medical had annual revenue of 8.79B TWD with 2.94% growth. Excelsior Medical had revenue of 2.28B in the quarter ending December 31, 2025, with 0.12% growth.
Revenue
8.79B
Revenue Growth
+2.94%
P/S Ratio
1.51
Revenue / Employee
63.69M
Employees
138
Market Cap
13.30B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 8.79B | 250.69M | 2.94% |
| Dec 31, 2024 | 8.54B | 305.14M | 3.71% |
| Dec 31, 2023 | 8.23B | 1.05B | 14.56% |
| Dec 31, 2022 | 7.19B | 613.68M | 9.34% |
| Dec 31, 2021 | 6.57B | -102.34M | -1.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bora Pharmaceuticals | 19.01B |
| Great Tree Pharmacy | 18.90B |
| PharmaEssentia | 15.63B |
| YungShin Global Holding | 8.37B |
| Visco Vision | 4.22B |
| TaiDoc Technology | 4.20B |
| Ever Supreme Bio Technology | 1.02B |
| TaiMed Biologics | 611.35M |